Crimson BioPharm Inc. — Form D
Crimson BioPharm Inc. of BROOKLINE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-15. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-10-15
- Form: D
- Accession: 0001791153-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 1
- Date of first sale: 2019-10-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-351088
Issuer
- Name: Crimson BioPharm Inc.
- CIK: 0001791173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 9 BRADFORD TERRACE, BROOKLINE, MA, 02446
- Phone: 617-632-2932
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Haiying Peng | Director | Brookline, MA |
| Thomas Roberts | Director | Denver, CO |
| Jean Zhao | Director | Brookline, MA |
| Haiying Peng | Executive Officer | Brookline, MA |
More